Cotherabio
San Mateo, US · 1 known investors
Cothera Bioscience is a clinical-stage biopharmaceutical company developing small molecule therapies targeting previously undruggable oncology targets through synthetic lethality, protein degradation, and immunotherapy mechanisms. The company's lead candidates are in Phase 2 trials for hematologic malignancies and high-grade gliomas with specific genetic mutations.
Investors · 1
Frequently asked questions
- What does Cotherabio do?
- Cothera Bioscience is a clinical-stage biopharmaceutical company developing small molecule therapies targeting previously undruggable oncology targets through synthetic lethality, protein degradation, and immunotherapy mechanisms. The company's lead candidates are in Phase 2 trials for hematologic malignancies and high-grade gliomas with specific genetic mutations.
- Who are Cotherabio's investors?
- Cotherabio's investors include Pan-Lin Capital.
- Where is Cotherabio headquartered?
- Cotherabio is headquartered in San Mateo, US.